| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/01/2011 | CN102078613A Inhibitors of her3 activity |
| 06/01/2011 | CN102078608A Formulation of human antibodies for treating tnf-alpha associated disorders |
| 06/01/2011 | CN101362795B Epitope of epididymal protease inhibitor B cell and antigen peptides containing thereof |
| 05/31/2011 | US7951959 Hydrophilic labels for biomolecules |
| 05/31/2011 | US7951933 Adenosine triphophate-ribosylcyclase for identifying modulators to prevent and treat autoimmune, skin and inflammatory disorders |
| 05/31/2011 | US7951923 Fluorescent proteins and chromoproteins from non-Aequorea hydrozoa species and methods for using same |
| 05/31/2011 | US7951921 Multivalent carriers of bi-specific antibodies |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951918 Stabilized polypeptide compositions |
| 05/31/2011 | US7951917 Method for making multispecific antibodies having heteromultimeric and common components |
| 05/31/2011 | US7951916 Il-1 related polypeptides |
| 05/31/2011 | US7951911 Carbon nanotube binding peptides |
| 05/31/2011 | US7951906 Compounds capable of interacting with a cell-surface fibroblast growth factor receptor |
| 05/31/2011 | US7951904 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 05/31/2011 | US7951614 Methods and compositions for the production of monoclonal antibodies |
| 05/31/2011 | US7951589 Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 05/31/2011 | US7951546 Compositions and methods for the diagnosis and treatment of tumor |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951373 Administering to mammal a neural growth and/or remyelination and/or neuroprotection promoting amount of an agent comprising a neural cell adhesion molecule, which molecule is capable of overcoming inhibitory molecular cues found on glial cells |
| 05/31/2011 | US7951372 Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof |
| 05/31/2011 | US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling |
| 05/31/2011 | US7951369 Chimeric, human and humanized anti-granulocyte antibodies and methods of use |
| 05/31/2011 | CA2400929C Antagonistic selective binding agents of osteoprotegerin binding protein |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2301942C Molecular mimetics of meningococcal b epitopes |
| 05/31/2011 | CA2237356C Methods for diagnosis and treatment of bloom's syndrome |
| 05/26/2011 | WO2011063348A1 Monomeric antibody fc |
| 05/26/2011 | WO2011063346A1 Targeting of the c-terminal segment of c. difficile toxin b for improved clinical diagnosis, prevention, and treatment |
| 05/26/2011 | WO2011063277A1 Anti-orai1 antigen binding proteins and uses thereof |
| 05/26/2011 | WO2011062803A2 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |
| 05/26/2011 | WO2011062634A2 Monoclonal antibodies and diagnostic uses thereof |
| 05/26/2011 | WO2011062563A1 Modulators of cell cycle progression |
| 05/26/2011 | WO2011062562A1 Hepatitis b virus specific antibody and uses thereof |
| 05/26/2011 | WO2011062560A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof |
| 05/26/2011 | WO2011062263A1 Pharmaceutical composition |
| 05/26/2011 | WO2011062207A1 Human artificial chromosome vector |
| 05/26/2011 | WO2011062206A1 Human artificial chromosome vector |
| 05/26/2011 | WO2011062112A1 Highly-functional mutant of humanized anti-egfr antibody variable region |
| 05/26/2011 | WO2011061944A1 Fluoroimmunoasssay method |
| 05/26/2011 | WO2011061937A1 Methods for producing antibody-producing cells that produce desired polypeptides |
| 05/26/2011 | WO2011061492A2 Multivalent antibodies |
| 05/26/2011 | WO2011061454A1 Use of polyvalent immunoglobulins for treating alcoholic or metabolic liver cirrhosis |
| 05/26/2011 | WO2011061246A2 Multivalent antibodies |
| 05/26/2011 | WO2011061194A1 Inhibitors of centrosomal clustering |
| 05/26/2011 | WO2011061119A1 Humanized antibodies against human il-22ra |
| 05/26/2011 | WO2011041584A3 Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products |
| 05/26/2011 | WO2011015602A3 Lung cancer biomarkers |
| 05/26/2011 | WO2011008092A3 Gram-positive bacteria specific binding compounds |
| 05/26/2011 | WO2010142423A3 Use of an anti-tau ps422 antibody for the treatment of brain diseases |
| 05/26/2011 | WO2010136311A3 Compositions and methods for antibodies targeting complement protein c3b |
| 05/26/2011 | WO2010107939A3 Human immunodeficiency virus (hiv) -neutralizing antibodies |
| 05/26/2011 | US20110126302 Diagnostic and therapeutic methods for efmr (epilepsy and mental retardation limited to females) |
| 05/26/2011 | US20110126301 Dendritic Cell Marker and Uses Thereof |
| 05/26/2011 | US20110124571 Opiorphin peptide derivatives as potent inhibitors of enkephalin-degrading ectopeptidases |
| 05/26/2011 | US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same |
| 05/26/2011 | US20110124550 Thymosin beta 4 promotes wound repair |
| 05/26/2011 | US20110124528 Generation and affinity maturation of antibody library in silico |
| 05/26/2011 | US20110124123 Method for examining wt1-related disease |
| 05/26/2011 | US20110124085 Unsymmetrical cyanine dimer compounds and their application |
| 05/26/2011 | US20110124045 Nucleic acids encoding recombinant protein a |
| 05/26/2011 | US20110124021 Phosphorylated fatty acid synthase and cancer |
| 05/26/2011 | US20110124009 Composition, kit and method for assaying neuropathy |
| 05/26/2011 | US20110124006 Method for screening of therapeutic agent for cancer |
| 05/26/2011 | US20110123603 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 05/26/2011 | US20110123591 Tumoricidal, bactericidal, or viricidal macrophage activation |
| 05/26/2011 | US20110123558 Peptide with Reduced Dimer Formation |
| 05/26/2011 | US20110123557 Anti-hmga1 monoclonal antibodies, process for their preparation and their use for the quantitative determination of hmga1 |
| 05/26/2011 | US20110123552 Agonistic binding molecules to the human OX40 receptor |
| 05/26/2011 | US20110123551 Hvem/btla, hvem/cd 160 and hvem/gd cis complexes and methods of use |
| 05/26/2011 | US20110123549 Antibodies to EphA3 |
| 05/26/2011 | US20110123544 Human antibodies that bind human il-12 and methods for producing |
| 05/26/2011 | US20110123543 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 05/26/2011 | US20110123541 Human Monoclonal Nicotine Specific Antibodies |
| 05/26/2011 | US20110123539 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer |
| 05/26/2011 | US20110123538 Composition comprising expression or activity inhibitors of ninjurin 1 for the prevention and treatment of inflammatory disease |
| 05/26/2011 | US20110123537 Binding epitopes for g250 antibody |
| 05/26/2011 | US20110123536 Novel human anti-r7v antibodies and uses thereof |
| 05/26/2011 | US20110123534 Novel compounds for modulating neovascularisation and methods of treatment using these compounds |
| 05/26/2011 | US20110123533 Using EGFRvIII to Identify and Target Cancer Stem Cells |
| 05/26/2011 | US20110123532 Method for Making Heteromultimeric Molecules |
| 05/26/2011 | US20110123531 Combination therapy |
| 05/26/2011 | US20110123529 Single domain antibodies directed against epidermal growth factor receptor and uses therefor |
| 05/26/2011 | US20110123528 Humanized anti-factor d antibodies and uses thereof |
| 05/26/2011 | US20110123523 Antibodies against erbb3 and uses thereof |
| 05/26/2011 | US20110123522 Methods of treating cancer using anti cd24 antibodies |
| 05/26/2011 | US20110123520 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| 05/26/2011 | US20110123519 Recombinant antigen |
| 05/26/2011 | US20110123494 Treatment with anti-vegf antibodies |
| 05/26/2011 | US20110123454 Method for modulating appetite |
| 05/26/2011 | US20110123448 Oil body carriers, uses in target therapy and/or detection of the same, and fusion proteins comprised therein |
| 05/26/2011 | US20110123447 Method of providing human tumor-specific antibodies |
| 05/26/2011 | US20110123442 Tumor specific antibodies and uses therefor |
| 05/26/2011 | US20110123441 Novel greb1a monoclonal antibody |
| 05/26/2011 | US20110123440 Altered Antibody FC Regions and Uses Thereof |
| 05/26/2011 | CA2818237A1 Targeting tumor cells with chemotherapeutic agents conjugated to matriptase antibodies |
| 05/26/2011 | CA2785376A1 Pharmaceutical composition |
| 05/26/2011 | CA2781539A1 Monomeric antibody fc |
| 05/26/2011 | CA2781532A1 Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1 |
| 05/26/2011 | CA2781255A1 Multiplex immunoassays for hemoglobin, hemoglobin variants, and glycated forms |